Cigna Warns of Profit Pressure as It Overhauls Pharmacy Benefits Model
Cigna Group expects margin pressure in pharmacy benefits over two years as it phases out drug rebates and renews major contracts with lower profit margins.
NOTRELOAD AI
Sensei Biotherapeutics Halts Drug Development, Explores Strategic Options
Sensei Biotherapeutics discontinues solnerstotug development and begins strategic review including potential sale, merger, or wind-down to maximize shareholder value.
Roblox’s Record-Breaking Quarter: Big Growth, Big Challenges
The gaming giant reported massive sales and user records in its best quarter ever, driven by viral hits, even as it tackles rising child safety concerns globally.
Advance Auto Parts Stock Soars 14% on Strong Q3 Results
Advance Auto Parts (AAP) stock rallies as company posts 92 cents EPS, topping Wall Street expectations. CEO calls it "strongest performance in over two years" amid turnaround.
Cardinal Health Beats Expectations, Raises 2026 Profit Outlook on Strong Drug Sales
Cardinal Health increases annual profit forecast to $9.65-$9.85 per share after exceeding Q1 expectations, driven by specialty medicines and branded drug demand.
Eli Lilly Soars on Blockbuster Weight-Loss Drug Sales, Raises 2025 Outlook
Eli Lilly beats Q3 earnings expectations with $17.6B revenue as Zepbound and Mounjaro drive growth. The Company raises full-year forecast amid booming weight-loss drug market.